PRIMA-1 significantly suppresses proliferation in mut-p53 glioma cells by inducing the transcription of genes positively regulated by p53, such as p21cip1, the growth arrest and DNA damage gene 45a, and mdm2. The gene discussed is CDKN1A; the disease is central nervous system cancer.